Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Burger

Showing results (851-860 of 1,123) with videos related to

Pageof 113
Sort By:
Cancer Chemotherapy and Pharmacology|October 4, 2024
A comparison of the renal function biomarkers serum creatinine, pro-enkephalin and cystatin C to predict clearance of pemetrexedN de Rouw, R Beunders, O Hartmann, et al.
Gynecologic Oncology|June 2, 2009
Adjuvant radiotherapy in patients with vulvar cancer and one intra capsular lymph node metastasis is not beneficialG Fons, S M A Groenen, M H M Oonk, et al.
The Journal of Antimicrobial Chemotherapy|January 17, 2019
Pharmacokinetics and probability of target attainment for micafungin in normal-weight and morbidly obese adultsRoeland E Wasmann, Cornelis Smit, Rob Ter Heine, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 14, 2017
Brief Report: High Need to Switch cART or Comedication With the Initiation of DAAs in Elderly HIV/HCV-Coinfected PatientsElise J Smolders, Colette Smit, Clara T M M de Kanter, et al.
Antimicrobial Agents and Chemotherapy|February 22, 2001
Pharmacokinetics of the protease inhibitor indinavir in human immunodeficiency virus type 1-infected childrenD M Burger, A M van Rossum, P W Hugen, et al.
The Journal of Antimicrobial Chemotherapy|February 5, 2019
Evaluating darunavir/ritonavir dosing regimens for HIV-positive pregnant women using semi-mechanistic pharmacokinetic modellingStein Schalkwijk, Rob Ter Heine, Angela Colbers, et al.
The Pediatric Infectious Disease Journal|August 23, 2002
Therapeutic drug monitoring of indinavir and nelfinavir to assess adherence to therapy in human immunodeficiency virus-infected childrenAnnemarie M van Rossum, Alina S Bergshoeff, Pieter L Fraaij, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 1997
Disruption of syntaxin-mediated protein interactions blocks neurotransmitter secretionV O'Connor, C Heuss, W M De Bello, et al.
HIV Clinical Trials|January 2, 2007
No virological failure in semen during properly suppressive antiretroviral therapy despite subtherapeutic local drug concentrationsSelwyn H Lowe, Annemarie M J Wensing, Jacqueline A H Droste, et al.
The Journal of Antimicrobial Chemotherapy|January 24, 2020
Implications for IV posaconazole dosing in the era of obesityRoeland E Wasmann, Cornelis Smit, Marieke H van Donselaar, et al.
Pageof 113

Showing results (851-860 of 1,123) with videos related to

Sort By:
Pageof 113
Cancer Chemotherapy and Pharmacology|October 4, 2024
A comparison of the renal function biomarkers serum creatinine, pro-enkephalin and cystatin C to predict clearance of pemetrexedN de Rouw, R Beunders, O Hartmann, et al.
Gynecologic Oncology|June 2, 2009
Adjuvant radiotherapy in patients with vulvar cancer and one intra capsular lymph node metastasis is not beneficialG Fons, S M A Groenen, M H M Oonk, et al.
The Journal of Antimicrobial Chemotherapy|January 17, 2019
Pharmacokinetics and probability of target attainment for micafungin in normal-weight and morbidly obese adultsRoeland E Wasmann, Cornelis Smit, Rob Ter Heine, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 14, 2017
Brief Report: High Need to Switch cART or Comedication With the Initiation of DAAs in Elderly HIV/HCV-Coinfected PatientsElise J Smolders, Colette Smit, Clara T M M de Kanter, et al.
Antimicrobial Agents and Chemotherapy|February 22, 2001
Pharmacokinetics of the protease inhibitor indinavir in human immunodeficiency virus type 1-infected childrenD M Burger, A M van Rossum, P W Hugen, et al.
The Journal of Antimicrobial Chemotherapy|February 5, 2019
Evaluating darunavir/ritonavir dosing regimens for HIV-positive pregnant women using semi-mechanistic pharmacokinetic modellingStein Schalkwijk, Rob Ter Heine, Angela Colbers, et al.
The Pediatric Infectious Disease Journal|August 23, 2002
Therapeutic drug monitoring of indinavir and nelfinavir to assess adherence to therapy in human immunodeficiency virus-infected childrenAnnemarie M van Rossum, Alina S Bergshoeff, Pieter L Fraaij, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 1997
Disruption of syntaxin-mediated protein interactions blocks neurotransmitter secretionV O'Connor, C Heuss, W M De Bello, et al.
HIV Clinical Trials|January 2, 2007
No virological failure in semen during properly suppressive antiretroviral therapy despite subtherapeutic local drug concentrationsSelwyn H Lowe, Annemarie M J Wensing, Jacqueline A H Droste, et al.
The Journal of Antimicrobial Chemotherapy|January 24, 2020
Implications for IV posaconazole dosing in the era of obesityRoeland E Wasmann, Cornelis Smit, Marieke H van Donselaar, et al.
Pageof 113